Study findings highlight the role of urodynamic studies in diagnosing problems after mesh removal. Mesh removal frequently results in bladder problems warranting careful investigation, researchers ...

Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...

Multimodal ultrasound (MMU) is feasible for the diagnosis of neurogenic bladder (NB) in pediatric patients, according to a study published online Jan. 17 in Scientific Reports. Applying low-frequency ...

Durvalumab shows promising results in trial led by London-based Institute of Cancer Research Doctors are hailing a drug that spares bladder cancer patients “life-changing” surgery and stops tumours ...